The data for SHIRE HUMAN GENETIC THERAPIES UK LIMITED shows a consistent trend of improving payment times over the past three periods. From the start of 2018 to the end of 2018, the average time to pay has decreased, with a significant decrease in the percentage of invoices paid later than 60 days. This trend suggests that the company is making efforts to improve their payment processes and pay suppliers in a timely manner.
The data for SHIRE HUMAN GENETIC THERAPIES UK LIMITED shows a relatively stable trend in payment times over the past three periods. There are no major fluctuations or spikes in any of the metrics, indicating that the company has a consistent payment process in place.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | |||||
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 |
SHIRE HUMAN GENETIC THERAPIES UK LIMITED is a dissolved private limited company, incorporated on 23 August 2000, based in the London region. Registered business activity: Non-trading company.
From Companies House records.